Embecta Corp.EMBC
Close of Friday, October 23, 2026 · Embecta Corp. is trading above its Pivot, OnlyAlpha's long-term trend line.
Price
$6.71
vs its Pivot
+1.8%
OnlyAlpha Score
69
Trend
Above its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| +19.4% | -42.4% | -51.4% | — | — |
Dividend: $0.32 a share over the last 12 months, a 4.77% yield at today's price.
Who runs and owns it
In these funds
Suppliers, customers and partners
Sells to EMBC
| Becton Dickinson | cannula supply agreement |
EMBC sells to
| Cencora | three largest distributors; ~42% of gross sales combined |
| McKesson | three largest distributors; ~42% of gross sales combined |
| Cardinal Health | three largest distributors; ~42% of gross sales combined |
From the companies' own annual reports filed with the SEC.
Get EMBC in your free daily emailAfter every close: whether EMBC is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track EMBC free → Full Stock check
Track EMBC free → Full Stock check